Clinical trial Recruiting at 1 site Observational Ages 6 to 16

Adaptation and tolerance of Essilor Stellest lenses in children with progressive myopia

Official title: Pilot Study on the Adaptation and Tolerance of Essilor® Myopia-control Spectacle Lenses

Run by Nantes University Hospital · NCT07340931 · Data updated 2026-11-12

This observational pilot tests how well children with progressive myopia adapt to and tolerate Essilor Stellest lenses in real life.

More Myopia trials

Quick facts

Study typeObservational
Ages6 Years to 16 Years
SexAll
Enrollment50 (estimated)
SponsorNantes University Hospital
Academic / other
Locations1 site (Nantes, Nantes)
StatusRecruiting
StartedJanuary 20, 2026
Main results expectedJanuary 20, 2027
Study endsJanuary 20, 2027
Registry record updatedJune 24, 2026
Trial IDNCT07340931 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6 to 16 with progressive myopia meeting inclusion criteria and no exclusion criteria.

Probably not a fit

Patients with strabismus, amblyopia, or syndromic myopia, or those not meeting progression criteria, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational pilot that looks at real-world use of Essilor Stellest myopia-control lenses in children aged 6 to 16 with progressive myopia. The study focuses on how easily children adjust to the lenses and how comfortable they are during everyday wear, aiming to understand long-term wear compliance. It does not involve a randomized intervention or new treatment, but rather monitors naturalistic outcomes in a clinical setting. Data collected include wear time, comfort, and basic refractive/axial length considerations as part of routine follow-up. The findings could inform clinicians about practicality and adherence to this optical approach in everyday life.

Why it matters

Potential benefit: If successful, the study could confirm good tolerability and adherence to Stellest lenses, supporting their use in slowing myopia progression.

How similar studies have gone: Previous optical myopia-control approaches have shown promise in real-world adherence, making this a relevant, though observational, step.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 6 to 16 years with progressive myopia.
* Spherical equivalent ≤ -0.50 D under cycloplegia and presence of at least one risk factor (age \< 10 years, progression ≥ 0.50 D/year, axial length increase ≥ 0.2 mm/year, high myopia ≤ -6.00 D and/or axial length ≥ 26 mm, both parents myopic, at least one parent highly myopic, or Asian origin).
* Patient covered by the French social security system.
* Patient and legal guardians providing oral non-opposition to participate in the study.

Exclusion Criteria:

* Patients with strabismus, amblyopia, or syndromic myopia

Where it's running

  • CHU Nantes - Ophthalmology Department
    Nantes, Nantes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.